Orgenesis Inc. (ORGS)

OTCMKTS · Delayed Price · Currency is USD

0.6450

+0.0500 (8.40%)

May 6, 2026, 9:40 AM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Nov '17 Nov 30, 2017	Nov '16 Nov 30, 2016	Nov '15 Nov 30, 2015
Octomera	533.00K	68.00K	35.17M	35.07M	-
Octomera Growth	683.82%	-99.81%	0.29%	-	-
Therapies	525.00K	515.00K	6.43M	11.93M	-
Therapies Growth	1.94%	-91.99%	-46.06%	-	-
Eliminations	-23.00K	-53.00K	-5.58M	-11.49M	-
Point-Of-Care Business	-	-	-	-	7.65M
Point-Of-Care Business Growth	-	-	-	-	96.26%
Total	1.04M	530.00K	36.03M	35.50M	7.65M
Total Growth	95.28%	-98.53%	1.47%	363.96%	96.26%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Nov '17 Nov 30, 2017	Nov '16 Nov 30, 2016	Nov '15 Nov 30, 2015
United States	942.00K	650.00	-	-	-
United States Growth	144823.08%	-	-	-	-
Total	942.00K	650.00	-	-	-
Total Growth	144823.08%	-	-	-	-

Source: S&P Global Market Intelligence.